pa-clinical-policy

To evaluate medical necessity for prior authorization, the Skill analyzes requested treatments against clinical policies, LCDs, and NCDs to identify documentation gaps and determine if clinical thresholds are met. It assesses medical necessity criteria specific to the payer's coverage determinations.

Yes, you can use FHIR Da Vinci PAS standards to check step therapy requirements for biologics. The Skill adheres to these regulatory guidelines for clinical decision support and identifies the required documentation and clinical thresholds to ensure successful authorization under step therapy protocols.

The best way to formulate an appeal strategy is to analyze the specific denial codes and use the Skill to generate structured guidance for peer-to-peer reviews and formal appeals. It provides targeted strategies for both commercial and Medicare plans based on the documented denial.

Yes, this prior authorization tool supports both commercial and Medicare plans. It evaluates coverage determinations and clinical policies across these payer types to help healthcare professionals assess medical necessity and navigate the specific appeal processes for each.

To identify documentation gaps during prior authorization, the Skill cross-references the submitted clinical information against the payer's required criteria and step therapy protocols. It highlights missing information needed to prove medical necessity and secure approval.

You should not rely solely on automated clinical policy evaluation when a prior authorization requires complex peer-to-peer clinical judgment beyond standard step therapy or medical necessity criteria. The Skill provides structured guidance and identifies gaps, but final determinations may require direct clinician oversight.